Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (DE:82W)
FRANKFURT:82W
Holding DE:82W?
Track your performance easily
82W Stock Chart & Stats
Day’s Range― - ―
52-Week Range€7.66 - €33.09
Previous CloseN/A
Volume1.67K
Average Volume (3M)1.52K
Market Cap
$5.91B
Enterprise Value€4.09B
Total Cash (Recent Filing)$1.51M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)64.7
Beta1.83
Next Earnings
Mar 03, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.40
Shares Outstanding210,101,490
10 Day Avg. Volume859
30 Day Avg. Volume1,520
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.90
Price to Cash Flow (P/CF)17.80
P/FCF Ratio19.20
Enterprise Value/Market Cap0.69
Enterprise Value/Revenue3.29
Enterprise Value/Gross Profit5.72
Enterprise Value/Ebitda34.24
Forecast
1Y Price Target
€26.95Price Target Upside5.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Hims & Hers Health News
Bulls Say, Bears Say
Bulls Say
Business Model And Market PotentialHims & Hers Health has a disruptive business model that delivers health services through a non-traditional, direct-to-consumer, cash-pay approach.
Marketing StrategyHims & Hers is expected to allocate its marketing dollars efficiently and opportunistically to acquire new users.
Web Traffic And Customer BaseHers brand continues to drive impressive web traffic growth, accelerating for the fourth consecutive month, showcasing strong customer base diversification.
Bears Say
Competitive PressureAmazon’s entrance into these markets signals growing competition for customers and is expected to impact the prices that HIMS can charge, its ability to grow and capture new customers, and its customer acquisition costs.
Market SentimentThe vast majority of investors lean negative on HIMS, with sentiment matching elevated short interest that's risen nearly three times this year to an all-time high of 42.6 million shares.
Regulatory ChallengesPharma manufacturers are increasing pressure on the FDA to restrict compounded GLP-1 products, which could limit HIMS' product launches and expansion strategy.
---
Ownership Overview
5.82% Insiders
14.92% Mutual Funds
0.06% Other Institutional Investors
55.32% Public Companies and Individual Investors
Website Traffic
The estimated number of people who visited one or more of the websites owned by Hims & Hers Health
Desktop Users
Mobile Users
82W FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was €7.66 and its highest was €33.09 in the past 12 months.
What is Hims & Hers Health’s market cap?
Hims & Hers Health’s market cap is $5.91B.
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is Mar 03, 2025 which is in 41 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Nov 04, 2024. The company reported €0.31 earnings per share for the quarter, beating the consensus estimate of €0.108 by €0.203.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Undervalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is 0.1.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 210,101,490 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of €0.31 in its last earnings report, beating expectations of €0.108. Following the earnings report the stock price went up 4.522%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Currently, no hedge funds are holding shares in DE:82W
---
Hims & Hers Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€26.95 (5.35% Upside)
€26.95 (5.35% Upside)
Blogger Sentiment
Bullish
DE:82W Sentiment 84%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
231.15%
12-Months-Change
Fundamentals
Return on Equity
26.35%
Trailing 12-Months
Asset Growth
45.52%
Trailing 12-Months
Company Description
Hims & Hers Health
Oaktree Acquisition Corp. is an emerging growth company, which engages in the provision of merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Patrick McCaney, Alexander Taubman and Mathew Pendo in 2019 and is headquartered in Los Angeles, CA.
---
82W Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with significant revenue growth and subscriber expansion. High retention rates in new product offerings like GLP-1 solutions and strategic initiatives such as share repurchases indicate robust business health. However, there are challenges related to gross margin decline and regulatory uncertainties affecting the weight loss specialty.Read More>---
82W Revenue Breakdown
96.60% Online
3.40% Wholesale
---
82W Stock 12 Month Forecast
Average Price Target
€26.95
▲(5.35% Upside)
Technical Analysis
Hims & Hers Health
―
Teladoc
―
American Well
―
LifeMD
―
Doximity
―
Butterfly Network
―
Thermo Fisher
―
Best Analysts Covering 82W
1 Year
1 Year Success Rate
7/7 ratings generated profit
1 Year Average Return
+123.01%
reiterated a buy rating 2 months ago
Copying Jonna Kim's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +123.01% per trade.
---